Chardan Capital Markets, LLC
Exhibit 10.30
Chardan Capital Markets, LLC
00 Xxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxx, XX 00000
| November 12, 2010 |
Via Email
0 Xxxxxx Xx.
XXX 00000
Xxxxxxxxx, Xxxxxx 91451
Attn: Xxx Xxxxx, Chief Executive Officer
|
|
Re: Termination of October 19, 2010 Letter Agreement
|
Dear Xx. Xxxxx,
This letter will confirm that notwithstanding the survival provisions reflected in that Termination Letter dated November 8, 2010, terminating that certain Letter Agreement dated October 19, 2010 (“Letter Agreement”) between BioCancell Therapeutics Inc. (“BioCancell”) and Chardan Capital Markets, LLC ("Chardan"), Chardan will not be entitled to receive any fees or monies or other compensation set forth in the Letter Agreement other than the reimbursement of actual out of pocket expenses paid by Chardan.
Please confirm your understanding of the foregoing of by countersigning where indicated below.
| Sincerely yours,
__________________________
Chardan Capital Markets, LLC
|
Acknowledged and agreed:
__________________________
